
Pharmacy Editor: Jay W. Marks, MD
GENERIC NAME: fluvoxamine
BRAND NAME: Luvox
DRUG CLASS AND MECHANISM: Fluvoxamine is a drug that is used for
treating several psychiatric disorders. It is in the class of drugs called
selective serotonin reuptake inhibitors (SSRIs), a class that also includes
fluoxetine (Prozac), sertraline (Zoloft), and paroxetine (Paxil). Selective
serotonin reuptake inhibitors affect neurotransmitters (chemicals) that nerves
in the brain use to communicate with each other. Many experts believe that an
imbalance in these neurotransmitters is the cause of depression and other
psychiatric disorders. Fluvoxamine works by inhibiting the uptake of serotonin
(a neurotransmitter) by nerve cells. Therefore, there is more serotonin
available to stimulate other nerves in the brain. Fluvoxamine was approved by
the FDA for the treatment of obsessive-compulsive disorder in December, 1994.
PRESCRIPTION: Yes
GENERIC AVAILABLE: Yes
PREPARATIONS: Tablets: 25, 50, 100 mg.
STORAGE: Tablets should be kept at room temperature, 15- 30°C
(59-86°F).
PRESCRIBED FOR: Fluvoxamine is used for treating obsessive-compulsive
disorder (OCD). However, like other SSRIs, it also has been used in the
treatment of major depression, management of obesity, bulimia, schizophrenia,
and panic disorder.
DOSING: The usual starting dose for adults is 50 mg given as a single
dose in the morning. The dose may be increased by 50 mg increments every 4-7
days to achieve the desired response. The maximum dose is 300 mg/day. Doses
greater than 100 mg should administered as a divided dose.
Children (8 to 17 years old) should start with 25 mg daily, and the dose may
be increased by 25 mg every 4-7 days up to a maximum of 200 mg/day. Doses
greater than 50 mg should be administered as a divided dose.
DRUG INTERACTIONS: All SSRIs, including fluvoxamine, should not be taken with
any of the mono-amine oxidase inhibitor (MAOI) class of antidepressants such as
isocarboxazid (Marplan), phenelzine (Nardil), tranylcypromine (Parnate), and
procarbazine (Matulane). Such combinations may lead to confusion, high blood
pressure, tremor, and increased activity. Fluvoxamine should not be administered
within 14 days of discontinuing an MAO inhibitor. This same type of interaction
also may occur with selegiline (Eldepryl), fenfluramine (Pondimin), and
dexfenfluramine (Redux). Fluvoxamine can inhibit the elimination of clozapine
(Clozaril), necessitating dosage reductions of clozapine. Fluvoxamine may also
inhibit the elimination and increase the blood levels of theophylline (Theodur,
Uniphyl), warfarin (Coumadin), alprazolam (Xanax), and triazolam (Halcion).
PREGNANCY: There are no adequate studies of fluvoxamine in pregnant
women.
NURSING MOTHERS: Fluvoxamine is excreted into breast milk. There are
no adequate studies in lactating women.
SIDE EFFECTS: Side effects of all SSRIs include anxiety, nervousness,
sweating, nausea, decreased appetite, constipation, diarrhea, dry mouth,
somnolence (sleepiness), dizziness, insomnia, and sexual disfunction.
Withdrawal of an SSRI may result in withdrawal symptoms. The most common
symptoms of withdrawal are dizziness, tiredness, tingling of the extremities,
nausea, vivid dreams, irritability, and poor mood. Other symptoms include visual
disturbances and headaches. Withdrawal reactions have been reported after an
average of 12 to 36 weeks of treatment, but after as few as 5 weeks. Although
most authorities recommend treatment discontinuation by gradually reducing the
dose, symptoms may still occur. Symptoms generally appear within a few days of
discontinuing medication and persist for an average of 12 days (up to 21 days).
They are relieved within 24 hours by re-administering the medication that was
discontinued.
Antidepressants may increase the risk of suicide in children and adolescents.
There are concerns that antidepressants may also induce suicides in adults.
Patients with major depression may experience worsening of depression or
suicidal thoughts regardless of whether or not they are treated. Therefore,
patients started on antidepressants should be closely observed for signs of
worsening suicidal thinking or changes in behavior.
Last Editorial Review: 12/13/2005
 |
 |
From the Doctors at MedicineNet.com  |
 |
 |
- sertraline, Zoloft - Information on the medication sertraline (Zoloft) a drug used to treat depression, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, social anxiety disorder, and postmenstrual dysphoric disorder. Article includes descriptions, uses, drug interactions, and side effects. Source:MedicineNet
- Obsessive Compulsive Disorder (OCD) - Obsessive Compulsive Disorder traits, treatment, symptoms Source:Psychology Today
- paroxetine, Paxil, Paxil CR - Reveals the medication paroxetine (Paxil, Paxil CR) a drug indicated for the management of depression, obsessive-compulsive disorders, panic disorders, and premenstrual dysphoric disorder. Article includes descriptions, uses, drug interactions, and side effects. Source:MedicineNet
- Read 39 more fluvoxamine related articles ...
|
| |
 |
Back to Medications Index